nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—liver cancer	0.377	1	CbGaD
Fosphenytoin—CYP2B6—Sorafenib—liver cancer	0.0828	0.249	CbGbCtD
Fosphenytoin—CYP2C8—Sorafenib—liver cancer	0.0627	0.188	CbGbCtD
Fosphenytoin—CYP2C19—Sorafenib—liver cancer	0.0526	0.158	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—liver cancer	0.0502	0.151	CbGbCtD
Fosphenytoin—CYP2C9—Sorafenib—liver cancer	0.0438	0.131	CbGbCtD
Fosphenytoin—CYP3A4—Sorafenib—liver cancer	0.0254	0.0764	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—liver cancer	0.0154	0.0463	CbGbCtD
Fosphenytoin—Oliguria—Epirubicin—liver cancer	0.000608	0.00293	CcSEcCtD
Fosphenytoin—Delirium—Doxorubicin—liver cancer	0.000603	0.0029	CcSEcCtD
Fosphenytoin—Dyskinesia—Epirubicin—liver cancer	0.000596	0.00287	CcSEcCtD
Fosphenytoin—Syncope—Sorafenib—liver cancer	0.000594	0.00286	CcSEcCtD
Fosphenytoin—Leukopenia—Sorafenib—liver cancer	0.000593	0.00286	CcSEcCtD
Fosphenytoin—Dysarthria—Epirubicin—liver cancer	0.000592	0.00285	CcSEcCtD
Fosphenytoin—Loss of consciousness—Sorafenib—liver cancer	0.000583	0.00281	CcSEcCtD
Fosphenytoin—Cough—Sorafenib—liver cancer	0.000578	0.00279	CcSEcCtD
Fosphenytoin—Skin discolouration—Doxorubicin—liver cancer	0.000574	0.00277	CcSEcCtD
Fosphenytoin—Ventricular extrasystoles—Doxorubicin—liver cancer	0.000574	0.00277	CcSEcCtD
Fosphenytoin—Hypertension—Sorafenib—liver cancer	0.000572	0.00276	CcSEcCtD
Fosphenytoin—Coordination abnormal—Epirubicin—liver cancer	0.000571	0.00275	CcSEcCtD
Fosphenytoin—Thinking abnormal—Doxorubicin—liver cancer	0.000566	0.00273	CcSEcCtD
Fosphenytoin—Cough increased—Doxorubicin—liver cancer	0.000566	0.00273	CcSEcCtD
Fosphenytoin—Myalgia—Sorafenib—liver cancer	0.000564	0.00272	CcSEcCtD
Fosphenytoin—Arthralgia—Sorafenib—liver cancer	0.000564	0.00272	CcSEcCtD
Fosphenytoin—Oliguria—Doxorubicin—liver cancer	0.000563	0.00271	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Epirubicin—liver cancer	0.00056	0.0027	CcSEcCtD
Fosphenytoin—Vaginal inflammation—Epirubicin—liver cancer	0.00056	0.0027	CcSEcCtD
Fosphenytoin—Injection site reaction—Epirubicin—liver cancer	0.000557	0.00268	CcSEcCtD
Fosphenytoin—Dermatitis contact—Epirubicin—liver cancer	0.000554	0.00267	CcSEcCtD
Fosphenytoin—Dry mouth—Sorafenib—liver cancer	0.000552	0.00266	CcSEcCtD
Fosphenytoin—Dyskinesia—Doxorubicin—liver cancer	0.000552	0.00266	CcSEcCtD
Fosphenytoin—Hyperkalaemia—Epirubicin—liver cancer	0.000551	0.00265	CcSEcCtD
Fosphenytoin—Dysarthria—Doxorubicin—liver cancer	0.000548	0.00264	CcSEcCtD
Fosphenytoin—Salivary hypersecretion—Epirubicin—liver cancer	0.000544	0.00262	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Sorafenib—liver cancer	0.000541	0.00261	CcSEcCtD
Fosphenytoin—Infection—Sorafenib—liver cancer	0.000537	0.00259	CcSEcCtD
Fosphenytoin—Shock—Sorafenib—liver cancer	0.000532	0.00256	CcSEcCtD
Fosphenytoin—Fluid retention—Epirubicin—liver cancer	0.000532	0.00256	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Sorafenib—liver cancer	0.00053	0.00255	CcSEcCtD
Fosphenytoin—Vaginal infection—Epirubicin—liver cancer	0.000529	0.00255	CcSEcCtD
Fosphenytoin—Coordination abnormal—Doxorubicin—liver cancer	0.000528	0.00254	CcSEcCtD
Fosphenytoin—Vaginal inflammation—Doxorubicin—liver cancer	0.000519	0.0025	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Doxorubicin—liver cancer	0.000519	0.0025	CcSEcCtD
Fosphenytoin—Anorexia—Sorafenib—liver cancer	0.000516	0.00248	CcSEcCtD
Fosphenytoin—Injection site reaction—Doxorubicin—liver cancer	0.000515	0.00248	CcSEcCtD
Fosphenytoin—Cramps of lower extremities—Epirubicin—liver cancer	0.000515	0.00248	CcSEcCtD
Fosphenytoin—Dermatitis contact—Doxorubicin—liver cancer	0.000512	0.00247	CcSEcCtD
Fosphenytoin—Coma—Epirubicin—liver cancer	0.000512	0.00247	CcSEcCtD
Fosphenytoin—Hyperkalaemia—Doxorubicin—liver cancer	0.000509	0.00245	CcSEcCtD
Fosphenytoin—Rash maculo-papular—Epirubicin—liver cancer	0.000509	0.00245	CcSEcCtD
Fosphenytoin—Ecchymosis—Epirubicin—liver cancer	0.000507	0.00244	CcSEcCtD
Fosphenytoin—Salivary hypersecretion—Doxorubicin—liver cancer	0.000504	0.00243	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000493	0.00237	CcSEcCtD
Fosphenytoin—Fluid retention—Doxorubicin—liver cancer	0.000492	0.00237	CcSEcCtD
Fosphenytoin—Vaginal infection—Doxorubicin—liver cancer	0.00049	0.00236	CcSEcCtD
Fosphenytoin—Mental disability—Epirubicin—liver cancer	0.000486	0.00234	CcSEcCtD
Fosphenytoin—Sepsis—Epirubicin—liver cancer	0.000486	0.00234	CcSEcCtD
Fosphenytoin—Dyspnoea—Sorafenib—liver cancer	0.000482	0.00232	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Epirubicin—liver cancer	0.000477	0.0023	CcSEcCtD
Fosphenytoin—Cramps of lower extremities—Doxorubicin—liver cancer	0.000476	0.00229	CcSEcCtD
Fosphenytoin—Dyspepsia—Sorafenib—liver cancer	0.000476	0.00229	CcSEcCtD
Fosphenytoin—Coma—Doxorubicin—liver cancer	0.000474	0.00228	CcSEcCtD
Fosphenytoin—Rash maculo-papular—Doxorubicin—liver cancer	0.000471	0.00227	CcSEcCtD
Fosphenytoin—Decreased appetite—Sorafenib—liver cancer	0.00047	0.00227	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Epirubicin—liver cancer	0.00047	0.00226	CcSEcCtD
Fosphenytoin—Ecchymosis—Doxorubicin—liver cancer	0.000469	0.00226	CcSEcCtD
Fosphenytoin—Constipation—Sorafenib—liver cancer	0.000463	0.00223	CcSEcCtD
Fosphenytoin—Eye pain—Epirubicin—liver cancer	0.000451	0.00217	CcSEcCtD
Fosphenytoin—Mental disability—Doxorubicin—liver cancer	0.00045	0.00217	CcSEcCtD
Fosphenytoin—Sepsis—Doxorubicin—liver cancer	0.00045	0.00217	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Epirubicin—liver cancer	0.000449	0.00216	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Doxorubicin—liver cancer	0.000441	0.00212	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Doxorubicin—liver cancer	0.000435	0.00209	CcSEcCtD
Fosphenytoin—Urticaria—Sorafenib—liver cancer	0.00043	0.00207	CcSEcCtD
Fosphenytoin—Body temperature increased—Sorafenib—liver cancer	0.000428	0.00206	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Epirubicin—liver cancer	0.00042	0.00202	CcSEcCtD
Fosphenytoin—Eye pain—Doxorubicin—liver cancer	0.000417	0.00201	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Doxorubicin—liver cancer	0.000415	0.002	CcSEcCtD
Fosphenytoin—Osteoarthritis—Epirubicin—liver cancer	0.000407	0.00196	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000407	0.00196	CcSEcCtD
Fosphenytoin—Diplopia—Epirubicin—liver cancer	0.000407	0.00196	CcSEcCtD
Fosphenytoin—Affect lability—Epirubicin—liver cancer	0.0004	0.00193	CcSEcCtD
Fosphenytoin—Migraine—Epirubicin—liver cancer	0.0004	0.00193	CcSEcCtD
Fosphenytoin—Face oedema—Epirubicin—liver cancer	0.000393	0.00189	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000389	0.00187	CcSEcCtD
Fosphenytoin—Asthenia—Sorafenib—liver cancer	0.000388	0.00187	CcSEcCtD
Fosphenytoin—Cardiac arrest—Epirubicin—liver cancer	0.000387	0.00186	CcSEcCtD
Fosphenytoin—Mood swings—Epirubicin—liver cancer	0.000385	0.00186	CcSEcCtD
Fosphenytoin—Pruritus—Sorafenib—liver cancer	0.000383	0.00184	CcSEcCtD
Fosphenytoin—Ataxia—Epirubicin—liver cancer	0.000382	0.00184	CcSEcCtD
Fosphenytoin—Dehydration—Epirubicin—liver cancer	0.000378	0.00182	CcSEcCtD
Fosphenytoin—Osteoarthritis—Doxorubicin—liver cancer	0.000376	0.00181	CcSEcCtD
Fosphenytoin—Diplopia—Doxorubicin—liver cancer	0.000376	0.00181	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000376	0.00181	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Epirubicin—liver cancer	0.000376	0.00181	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Epirubicin—liver cancer	0.000372	0.00179	CcSEcCtD
Fosphenytoin—Affect lability—Doxorubicin—liver cancer	0.00037	0.00178	CcSEcCtD
Fosphenytoin—Migraine—Doxorubicin—liver cancer	0.00037	0.00178	CcSEcCtD
Fosphenytoin—Hypokalaemia—Epirubicin—liver cancer	0.00037	0.00178	CcSEcCtD
Fosphenytoin—Diarrhoea—Sorafenib—liver cancer	0.00037	0.00178	CcSEcCtD
Fosphenytoin—Face oedema—Doxorubicin—liver cancer	0.000363	0.00175	CcSEcCtD
Fosphenytoin—Gastritis—Epirubicin—liver cancer	0.00036	0.00173	CcSEcCtD
Fosphenytoin—Muscular weakness—Epirubicin—liver cancer	0.000359	0.00173	CcSEcCtD
Fosphenytoin—Cardiac arrest—Doxorubicin—liver cancer	0.000358	0.00172	CcSEcCtD
Fosphenytoin—Dizziness—Sorafenib—liver cancer	0.000358	0.00172	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—liver cancer	0.000357	0.00172	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—liver cancer	0.000354	0.0017	CcSEcCtD
Fosphenytoin—Influenza—Epirubicin—liver cancer	0.000352	0.00169	CcSEcCtD
Fosphenytoin—Dysphagia—Epirubicin—liver cancer	0.000352	0.00169	CcSEcCtD
Fosphenytoin—Asthma—Epirubicin—liver cancer	0.000352	0.00169	CcSEcCtD
Fosphenytoin—Dehydration—Doxorubicin—liver cancer	0.00035	0.00169	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—liver cancer	0.000347	0.00167	CcSEcCtD
Fosphenytoin—Vomiting—Sorafenib—liver cancer	0.000344	0.00166	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—liver cancer	0.000344	0.00166	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—liver cancer	0.000343	0.00165	CcSEcCtD
Fosphenytoin—Rash—Sorafenib—liver cancer	0.000341	0.00164	CcSEcCtD
Fosphenytoin—Dermatitis—Sorafenib—liver cancer	0.000341	0.00164	CcSEcCtD
Fosphenytoin—Headache—Sorafenib—liver cancer	0.000339	0.00163	CcSEcCtD
Fosphenytoin—Bronchitis—Epirubicin—liver cancer	0.000338	0.00163	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—liver cancer	0.000333	0.0016	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—liver cancer	0.000332	0.0016	CcSEcCtD
Fosphenytoin—Dysuria—Epirubicin—liver cancer	0.000329	0.00158	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—liver cancer	0.000325	0.00157	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—liver cancer	0.000325	0.00157	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—liver cancer	0.000325	0.00157	CcSEcCtD
Fosphenytoin—Nausea—Sorafenib—liver cancer	0.000321	0.00155	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Epirubicin—liver cancer	0.000321	0.00155	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Epirubicin—liver cancer	0.000317	0.00153	CcSEcCtD
Fosphenytoin—Pneumonia—Epirubicin—liver cancer	0.000315	0.00152	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—liver cancer	0.000313	0.00151	CcSEcCtD
Fosphenytoin—Renal failure—Epirubicin—liver cancer	0.000308	0.00148	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—liver cancer	0.000305	0.00147	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—liver cancer	0.000304	0.00147	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—liver cancer	0.000301	0.00145	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—liver cancer	0.000297	0.00143	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—liver cancer	0.000296	0.00142	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—liver cancer	0.000294	0.00142	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—liver cancer	0.000293	0.00141	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—liver cancer	0.000292	0.00141	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—liver cancer	0.000286	0.00138	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—liver cancer	0.000285	0.00137	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—liver cancer	0.000282	0.00136	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—liver cancer	0.000282	0.00136	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—liver cancer	0.00028	0.00135	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—liver cancer	0.000279	0.00135	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—liver cancer	0.000278	0.00134	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—liver cancer	0.000274	0.00132	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—liver cancer	0.000272	0.00131	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—liver cancer	0.000265	0.00128	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—liver cancer	0.000262	0.00126	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—liver cancer	0.000261	0.00126	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—liver cancer	0.000259	0.00125	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—liver cancer	0.000258	0.00124	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—liver cancer	0.000252	0.00122	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—liver cancer	0.000243	0.00117	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—liver cancer	0.000241	0.00116	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—liver cancer	0.00024	0.00116	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—liver cancer	0.00024	0.00116	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—liver cancer	0.000238	0.00115	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—liver cancer	0.000237	0.00114	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—liver cancer	0.000236	0.00113	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—liver cancer	0.000234	0.00113	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—liver cancer	0.000227	0.00109	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—liver cancer	0.000226	0.00109	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—liver cancer	0.000225	0.00108	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—liver cancer	0.000223	0.00108	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—liver cancer	0.000222	0.00107	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—liver cancer	0.000222	0.00107	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—liver cancer	0.000221	0.00106	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—liver cancer	0.00022	0.00106	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—liver cancer	0.00022	0.00106	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—liver cancer	0.00022	0.00106	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—liver cancer	0.000219	0.00106	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—liver cancer	0.000219	0.00106	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—liver cancer	0.000218	0.00105	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—liver cancer	0.000216	0.00104	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—liver cancer	0.000215	0.00104	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—liver cancer	0.000214	0.00103	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—liver cancer	0.000212	0.00102	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—liver cancer	0.000211	0.00102	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—liver cancer	0.00021	0.00101	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—liver cancer	0.000209	0.00101	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—liver cancer	0.000209	0.001	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—liver cancer	0.000209	0.001	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—liver cancer	0.000208	0.001	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—liver cancer	0.000206	0.000993	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—liver cancer	0.000204	0.000985	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—liver cancer	0.000204	0.000982	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—liver cancer	0.000204	0.000981	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—liver cancer	0.000203	0.000979	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—liver cancer	0.000203	0.000977	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—liver cancer	0.000202	0.000971	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—liver cancer	0.0002	0.000965	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—liver cancer	0.0002	0.000963	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—liver cancer	0.000199	0.00096	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—liver cancer	0.000199	0.000957	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—liver cancer	0.000198	0.000953	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—liver cancer	0.000197	0.000947	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—liver cancer	0.000196	0.000946	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—liver cancer	0.000196	0.000943	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—liver cancer	0.000196	0.000943	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—liver cancer	0.000195	0.00094	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—liver cancer	0.000193	0.000931	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—liver cancer	0.000193	0.00093	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—liver cancer	0.000193	0.00093	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—liver cancer	0.000191	0.000918	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—liver cancer	0.000191	0.000918	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—liver cancer	0.000189	0.000909	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—liver cancer	0.000187	0.0009	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—liver cancer	0.000187	0.000898	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—liver cancer	0.000185	0.000891	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—liver cancer	0.000184	0.000885	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000182	0.000877	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—liver cancer	0.000182	0.000877	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—liver cancer	0.000181	0.000872	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—liver cancer	0.000181	0.000871	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—liver cancer	0.000181	0.00087	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—liver cancer	0.00018	0.000865	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—liver cancer	0.000179	0.000861	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—liver cancer	0.000178	0.000859	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—liver cancer	0.000178	0.000856	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—liver cancer	0.000176	0.000849	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—liver cancer	0.000176	0.000848	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—liver cancer	0.000174	0.000837	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—liver cancer	0.000173	0.000833	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—liver cancer	0.000171	0.000824	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000169	0.000812	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—liver cancer	0.000167	0.000806	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—liver cancer	0.000166	0.0008	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—liver cancer	0.000165	0.000794	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—liver cancer	0.000165	0.000794	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—liver cancer	0.000164	0.000792	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—liver cancer	0.000163	0.000784	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—liver cancer	0.000161	0.000775	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—liver cancer	0.000159	0.000765	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—liver cancer	0.000158	0.000762	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—liver cancer	0.000158	0.000761	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—liver cancer	0.000152	0.000734	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—liver cancer	0.000147	0.000708	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—liver cancer	0.000146	0.000704	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—liver cancer	0.000143	0.000691	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—liver cancer	0.000141	0.000681	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—liver cancer	0.000137	0.000659	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—liver cancer	0.000133	0.000639	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—liver cancer	0.000132	0.000637	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—liver cancer	0.000131	0.00063	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—liver cancer	0.000127	0.000612	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—liver cancer	0.000127	0.00061	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—liver cancer	0.000126	0.000607	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—liver cancer	0.000126	0.000607	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—liver cancer	0.000125	0.000603	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—liver cancer	0.000122	0.000589	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—liver cancer	0.000119	0.000572	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—liver cancer	0.000118	0.000567	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—liver cancer	0.000117	0.000562	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—liver cancer	0.000117	0.000561	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—liver cancer	0.000116	0.000558	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—liver cancer	0.00011	0.000529	CcSEcCtD
Fosphenytoin—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	3.35e-05	0.000409	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—ABL1—liver cancer	3.34e-05	0.000407	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IGF2—liver cancer	3.32e-05	0.000405	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTA4—liver cancer	3.29e-05	0.000401	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TNF—liver cancer	3.23e-05	0.000394	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CPT1B—liver cancer	3.21e-05	0.000392	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GLUL—liver cancer	3.21e-05	0.000392	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTA2—liver cancer	3.21e-05	0.000391	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—KRAS—liver cancer	3.2e-05	0.00039	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GLUL—liver cancer	3.19e-05	0.00039	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CPT1B—liver cancer	3.19e-05	0.00039	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	3.18e-05	0.000388	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—HGF—liver cancer	3.14e-05	0.000383	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.11e-05	0.000379	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—CSF2—liver cancer	3.1e-05	0.000378	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NR1H4—liver cancer	3.1e-05	0.000378	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTA1—liver cancer	3.09e-05	0.000377	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NR1H4—liver cancer	3.08e-05	0.000376	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NAT2—liver cancer	3.06e-05	0.000373	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTA3—liver cancer	3.05e-05	0.000371	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTA3—liver cancer	3.03e-05	0.000369	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALDOB—liver cancer	2.93e-05	0.000358	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	2.91e-05	0.000355	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CPT1B—liver cancer	2.87e-05	0.00035	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GLUL—liver cancer	2.87e-05	0.00035	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—UGDH—liver cancer	2.85e-05	0.000347	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.83e-05	0.000345	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CRABP1—liver cancer	2.8e-05	0.000341	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTA4—liver cancer	2.79e-05	0.00034	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTA4—liver cancer	2.77e-05	0.000338	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NR1H4—liver cancer	2.77e-05	0.000337	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.72e-05	0.000332	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—HRAS—liver cancer	2.72e-05	0.000332	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTA3—liver cancer	2.72e-05	0.000332	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTA2—liver cancer	2.71e-05	0.000331	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.71e-05	0.00033	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.7e-05	0.00033	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTA2—liver cancer	2.7e-05	0.000329	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—EPT1—liver cancer	2.68e-05	0.000326	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTA1—liver cancer	2.62e-05	0.000319	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CPT1B—liver cancer	2.61e-05	0.000319	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GLUL—liver cancer	2.61e-05	0.000319	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTA1—liver cancer	2.6e-05	0.000318	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—IL6—liver cancer	2.6e-05	0.000318	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NAT2—liver cancer	2.59e-05	0.000316	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NAT2—liver cancer	2.57e-05	0.000314	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TAT—liver cancer	2.54e-05	0.000309	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NR1H4—liver cancer	2.52e-05	0.000308	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MAPK14—liver cancer	2.51e-05	0.000306	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.49e-05	0.000304	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTA4—liver cancer	2.49e-05	0.000303	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALDOB—liver cancer	2.48e-05	0.000303	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.48e-05	0.000303	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTA3—liver cancer	2.48e-05	0.000302	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.48e-05	0.000302	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ALDOB—liver cancer	2.47e-05	0.000301	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—HPGDS—liver cancer	2.45e-05	0.000298	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—F2—liver cancer	2.43e-05	0.000297	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.43e-05	0.000296	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTA2—liver cancer	2.42e-05	0.000296	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—AKT1—liver cancer	2.4e-05	0.000293	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CRABP1—liver cancer	2.37e-05	0.000289	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CRABP1—liver cancer	2.36e-05	0.000287	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.35e-05	0.000287	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTA1—liver cancer	2.34e-05	0.000285	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CG—liver cancer	2.33e-05	0.000284	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NAT2—liver cancer	2.31e-05	0.000282	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTA4—liver cancer	2.27e-05	0.000277	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.22e-05	0.000271	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALDOB—liver cancer	2.22e-05	0.00027	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.22e-05	0.00027	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTA2—liver cancer	2.21e-05	0.000269	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PSMA4—liver cancer	2.18e-05	0.000266	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PSMD10—liver cancer	2.18e-05	0.000266	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.13e-05	0.00026	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTA1—liver cancer	2.13e-05	0.00026	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.12e-05	0.000259	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GOT2—liver cancer	2.12e-05	0.000259	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CRABP1—liver cancer	2.11e-05	0.000258	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.11e-05	0.000257	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NAT2—liver cancer	2.11e-05	0.000257	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HPGDS—liver cancer	2.07e-05	0.000253	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HPGDS—liver cancer	2.06e-05	0.000251	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.06e-05	0.000251	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CD—liver cancer	2.05e-05	0.00025	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.05e-05	0.00025	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.03e-05	0.000247	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SERPINE1—liver cancer	2.03e-05	0.000247	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALDOB—liver cancer	2.02e-05	0.000246	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP2E1—liver cancer	1.99e-05	0.000243	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CRABP1—liver cancer	1.93e-05	0.000235	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.9e-05	0.000232	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.87e-05	0.000229	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYCS—liver cancer	1.87e-05	0.000228	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.86e-05	0.000227	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.85e-05	0.000226	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HPGDS—liver cancer	1.85e-05	0.000225	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PSMA4—liver cancer	1.85e-05	0.000225	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PSMD10—liver cancer	1.85e-05	0.000225	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.84e-05	0.000224	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PSMD10—liver cancer	1.83e-05	0.000224	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PSMA4—liver cancer	1.83e-05	0.000224	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GOT1—liver cancer	1.83e-05	0.000223	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GGT1—liver cancer	1.83e-05	0.000223	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—RAF1—liver cancer	1.83e-05	0.000223	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GOT2—liver cancer	1.79e-05	0.000219	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GOT2—liver cancer	1.78e-05	0.000218	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CB—liver cancer	1.78e-05	0.000218	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.74e-05	0.000212	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CPT1B—liver cancer	1.72e-05	0.00021	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GLUL—liver cancer	1.72e-05	0.00021	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.72e-05	0.00021	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP2E1—liver cancer	1.69e-05	0.000206	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HPGDS—liver cancer	1.68e-05	0.000206	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP2E1—liver cancer	1.68e-05	0.000205	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.68e-05	0.000204	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.67e-05	0.000204	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NR1H4—liver cancer	1.66e-05	0.000203	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.65e-05	0.000201	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PSMA4—liver cancer	1.65e-05	0.000201	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PSMD10—liver cancer	1.65e-05	0.000201	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTP1—liver cancer	1.64e-05	0.000201	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—liver cancer	1.64e-05	0.0002	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA3—liver cancer	1.63e-05	0.000199	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.63e-05	0.000199	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.62e-05	0.000198	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—HMOX1—liver cancer	1.62e-05	0.000198	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GOT2—liver cancer	1.6e-05	0.000195	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.58e-05	0.000193	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYCS—liver cancer	1.58e-05	0.000193	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYCS—liver cancer	1.57e-05	0.000192	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GGT1—liver cancer	1.55e-05	0.000189	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GOT1—liver cancer	1.55e-05	0.000189	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GGT1—liver cancer	1.54e-05	0.000188	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GOT1—liver cancer	1.54e-05	0.000188	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.53e-05	0.000186	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTM1—liver cancer	1.51e-05	0.000184	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP2E1—liver cancer	1.51e-05	0.000184	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.51e-05	0.000184	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PSMD10—liver cancer	1.5e-05	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PSMA4—liver cancer	1.5e-05	0.000183	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA4—liver cancer	1.5e-05	0.000182	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GOT2—liver cancer	1.46e-05	0.000178	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.46e-05	0.000178	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA2—liver cancer	1.46e-05	0.000178	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP1A1—liver cancer	1.43e-05	0.000175	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYCS—liver cancer	1.41e-05	0.000172	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA1—liver cancer	1.41e-05	0.000171	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—liver cancer	1.39e-05	0.00017	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTP1—liver cancer	1.39e-05	0.00017	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NAT2—liver cancer	1.39e-05	0.00017	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTP1—liver cancer	1.38e-05	0.000169	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GOT1—liver cancer	1.38e-05	0.000169	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GGT1—liver cancer	1.38e-05	0.000169	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP2E1—liver cancer	1.37e-05	0.000168	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HMOX1—liver cancer	1.37e-05	0.000167	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HMOX1—liver cancer	1.36e-05	0.000166	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—MTHFR—liver cancer	1.34e-05	0.000163	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALDOB—liver cancer	1.33e-05	0.000163	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.33e-05	0.000162	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PPARA—liver cancer	1.31e-05	0.00016	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYCS—liver cancer	1.29e-05	0.000157	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTM1—liver cancer	1.28e-05	0.000156	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TGFB1—liver cancer	1.28e-05	0.000156	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTM1—liver cancer	1.27e-05	0.000155	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CRABP1—liver cancer	1.27e-05	0.000155	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GOT1—liver cancer	1.26e-05	0.000154	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GGT1—liver cancer	1.26e-05	0.000154	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTP1—liver cancer	1.24e-05	0.000152	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HMOX1—liver cancer	1.23e-05	0.000149	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP1A1—liver cancer	1.21e-05	0.000148	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP1A1—liver cancer	1.21e-05	0.000147	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—KRAS—liver cancer	1.18e-05	0.000144	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTM1—liver cancer	1.14e-05	0.000139	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTP1—liver cancer	1.13e-05	0.000138	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—MTHFR—liver cancer	1.13e-05	0.000138	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—MTHFR—liver cancer	1.12e-05	0.000137	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CG—liver cancer	1.12e-05	0.000137	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HMOX1—liver cancer	1.12e-05	0.000136	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HPGDS—liver cancer	1.11e-05	0.000136	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PPARA—liver cancer	1.11e-05	0.000135	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPARA—liver cancer	1.1e-05	0.000134	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CA—liver cancer	1.09e-05	0.000133	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PPARG—liver cancer	1.08e-05	0.000132	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP1A1—liver cancer	1.08e-05	0.000132	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—liver cancer	1.05e-05	0.000128	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTM1—liver cancer	1.04e-05	0.000127	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—MTHFR—liver cancer	1.01e-05	0.000123	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—HRAS—liver cancer	1.01e-05	0.000123	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.96e-06	0.000122	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.9e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PSMA4—liver cancer	9.9e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PSMD10—liver cancer	9.9e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPARA—liver cancer	9.9e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP1A1—liver cancer	9.87e-06	0.00012	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CD—liver cancer	9.86e-06	0.00012	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALB—liver cancer	9.74e-06	0.000119	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GOT2—liver cancer	9.63e-06	0.000118	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CG—liver cancer	9.5e-06	0.000116	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CG—liver cancer	9.44e-06	0.000115	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—MTHFR—liver cancer	9.2e-06	0.000112	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PPARG—liver cancer	9.17e-06	0.000112	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PPARG—liver cancer	9.11e-06	0.000111	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2E1—liver cancer	9.06e-06	0.00011	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPARA—liver cancer	9.03e-06	0.00011	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.89e-06	0.000108	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—AKT1—liver cancer	8.89e-06	0.000108	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CB—liver cancer	8.6e-06	0.000105	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CG—liver cancer	8.48e-06	0.000103	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYCS—liver cancer	8.48e-06	0.000103	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CD—liver cancer	8.35e-06	0.000102	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GGT1—liver cancer	8.32e-06	0.000101	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GOT1—liver cancer	8.32e-06	0.000101	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CD—liver cancer	8.3e-06	0.000101	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALB—liver cancer	8.24e-06	0.000101	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PPARG—liver cancer	8.18e-06	9.98e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.11e-06	9.89e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CG—liver cancer	7.73e-06	9.43e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTP1—liver cancer	7.47e-06	9.11e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PPARG—liver cancer	7.46e-06	9.1e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CD—liver cancer	7.45e-06	9.09e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HMOX1—liver cancer	7.37e-06	8.99e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALB—liver cancer	7.36e-06	8.97e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CB—liver cancer	7.28e-06	8.88e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CB—liver cancer	7.24e-06	8.83e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTM1—liver cancer	6.86e-06	8.37e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CD—liver cancer	6.79e-06	8.29e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALB—liver cancer	6.71e-06	8.18e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP1A1—liver cancer	6.51e-06	7.94e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CB—liver cancer	6.5e-06	7.92e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTHFR—liver cancer	6.07e-06	7.4e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARA—liver cancer	5.95e-06	7.26e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CB—liver cancer	5.92e-06	7.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CA—liver cancer	5.24e-06	6.39e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CG—liver cancer	5.1e-06	6.22e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARG—liver cancer	4.92e-06	6e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CD—liver cancer	4.48e-06	5.47e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CA—liver cancer	4.44e-06	5.41e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALB—liver cancer	4.42e-06	5.4e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CA—liver cancer	4.41e-06	5.38e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—AKT1—liver cancer	4.28e-06	5.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CA—liver cancer	3.96e-06	4.83e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CB—liver cancer	3.91e-06	4.76e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—AKT1—liver cancer	3.62e-06	4.42e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CA—liver cancer	3.61e-06	4.4e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—AKT1—liver cancer	3.6e-06	4.4e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—AKT1—liver cancer	3.23e-06	3.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—AKT1—liver cancer	2.95e-06	3.6e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CA—liver cancer	2.38e-06	2.9e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AKT1—liver cancer	1.95e-06	2.37e-05	CbGpPWpGaD
